First late effects study since new treatments were introduced found high prevalence of hearing loss, growth failure, underweight and lung disease Globally, neuroblastoma accounts for 8–10 percent of childhood cancers. It is generally diagnosed at a median age of 17–18 months, with…
From these early results, the researchers believe that overactive platelets likely drive disease progression and could be an overlooked target for improving the body’s immune response to glioblastoma and other types of tumors. They also believe that hormones likely regulate…
New sites in the UK, France, Sweden, Germany, Italy and Spain will add to the global footprint of the pivotal SIGMA study Study site locations will be listed on ClinicalTrials.gov and updated as finalized. In August 2026, the FDA granted…
(L to R) Qianqian Li, PhD; Dana Farmer, PhD; first author Justin Williams, PhD; corresponding author Martine Roussel, PhD, all of St. Jude Department of Tumor Cell Biology, and Jake Friske, PhD, St. Jude Graduate School of Biomedical Sciences Pediatric brain…
At the same time, antibody based therapies— despite their success in peripheral tumors— largely fail to access the brain parenchyma at therapeutically relevant levels. This disconnect has driven an urgent need for new BBB transport routes that are both selective…
WSW, NY, October 19th, 2026, FinanceWire FDA clearance doubles REGAIN’s permitted enrollment and broadens its clinical assessments, as Alpha Tau prepares to present updated results in November. A difficult cancer leaves little room for conventional treatment Alpha Tau is testing precisely that…
Astrocytomas and oligodendrogliomas are isocitrate dehydrogenase (IDH)-mutant gliomas that most commonly arise in adults under the age of 50 and exhibit variable responses to treatment 1â3. To understand the genetic drivers of disease progression,... Uncover the latest and most impactful research…
A new $35 million research center at Penn will develop novel approaches to treat brain cancers. “There can be no quit in this game," said neurosurgeon Nduka Amankulor, who will direct the center. Penn Medicine neurosurgeon Nduka Amankulor believes that harnessing…
Neurofibromatosis type 1 (NF1) is a common genetic disorder of deregulated cell growth, affecting approximately 100,000 Americans. People with NF1 are at an increased risk of developing a variety of benign and malignant tumors. There are limited therapies and no cures for NF1. At this…
1 in 8 women in the US will be diagnosed with breast cancer during their lifetime. Help fund lifesaving research and access to care, giving families like Gina’s more moments together. The amount must be greater than or equal to $5 Most salivary…
Brain tumours in adults and children: glioblastoma, glioma, meningioma, treatment and research.
An article joins this feed when it matches these terms. Each one is also a search of its own.